1.Montoya, JG, Liesenfeld, O. Toxoplasmosis. Lancet 2004; 363: 1965–1976.
2.Jones, JL, et al. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. American Journal of Tropical Medicine and Hygiene 2007; 77: 405–410.
3.Diza, E, et al. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clinical Microbiology & Infection 2005; 11: 719–723.
4.Berger, F, et al. Toxoplasmosis among pregnant women in France: Risk factors and change of prevalence between 1995 and 2003. Revue d'Épidémiologie, Médecine Sociale et Santé Publique 2009; 57: 241–248.
5.Hofhuis, A, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiology and Infection 2010; 24: 1–9.
6.Bénard, A, et al. European Toxo Prevention Study Group (EUROTOXO): survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Eurosurveillance 2008; 13: 1–13.
7.Stagni, L, et al. Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Memorias do Instituto Oswaldo Cruz 2009; 104: 374–377.
8.De Paschale, M, et al. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clinical Microbiology and Infection 2008; 14: 186–189.
9.De Paschale, M, et al. Implementation of screening for Toxoplasma gondii infection in pregnancy. Journal of Clinical and Medical Research 2010; 3: 112–116.
10.Stricker, R, et al. Toxoplasmosis during pregnancy and infancy. Swiss Medical Weekly 2009; 139: 643–644.
11.Dubey, JP. Toxoplasmosis of Animals and Humans, 2nd edn. Boca Raton, FL: CRC Press, 2010, pp. 313.
12.Castelli, F, et al. Aspetti epidemiologici della toxoplasmosi connatale. Rivista di Parassitologia 1995; 12: 19–23.
13.Valcavi, PP, et al. Prevalence of anti-Toxoplasma gondii antibodies in the population of the area of Parma (Italy). European Journal of Epidemiology 1995; 11: 333–337.
14.Pinto, B, et al. Seroprevalence for toxoplasmosis in individuals living in North West Tuscany: access to Toxo-tes in central Italy. European Journal of Clinical Microbiology & Infectious Disease 2012; 31: 1151–1156.